Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Wuhan YZY Biopharma Co., Ltd. Class H ( (HK:2496) ) has shared an announcement.
Wuhan YZY Biopharma Co., Ltd. has announced its Annual General Meeting to be held on June 25, 2025, in Wuhan, Hubei Province, PRC. The meeting will address several key resolutions, including the approval of the 2024 Annual Report, financial report, and profit distribution plan. Additionally, the reappointment of Deloitte Touche Tohmatsu as the company’s auditor for 2025 will be considered. Significant changes in the company’s governance are also on the agenda, with elections for new board members and supervisory committee representatives. These decisions are pivotal for the company’s strategic direction and governance structure, potentially impacting its market position and stakeholder interests.
More about Wuhan YZY Biopharma Co., Ltd. Class H
Average Trading Volume: 2,240
Technical Sentiment Signal: Sell
See more data about 2496 stock on TipRanks’ Stock Analysis page.